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Summary Hepatocyte suspensions were transplanted to the livers of syngeneic Wistar Kyoto rats by means
of intraportal injection. Labelling of the donor cells with "Cr or tritiated thymidine showed that 20% of the
cells survived the transplantation procedure and were permanently retained by the recipient liver. Hepatocytes
transplanted from normal livers produced no tumours, whereas donor cells from preneoplastic livers of rats
treated with the carcinogens diethylnitrosamine and 2-acetylaminofluorene produced neoplastic nodules and
hepatocellular carcinomas in the recipients. The number of tumours per host liver was proportional to the
number of hepatocytes transplanted. Treatment of the host rats with phenobarbitone accelerated tumour
development, causing liver cancer in the majority of the animals within three months. As opposed to the
polyploid surrounding liver, both phenobarbitone-promoted and unpromoted host tumours contained
predominantly (70-90%) diploid cells, regardless of the wide range of transplant ploidies (10-80% diploid
cells) achieved by means of centrifugal elutriation. The results indicate that all host tumours arise from
diploid donor hepatocytes and that the acquisition of a constitutive, predominantly non-polyploidising growth
pattern may be a characteristic property of hepatocellular tumours.
Cells isolated from the livers of carcinogen-treated rats have
been shown to proliferate after transplantation to the spleen
(Finkelstein et al., 1983) or liver (Laishes & Rolfe, 1980;
Hanigan & Pitot, 1985; Saeter et al., 1987) of syngeneic
hosts. The transplanted cells first form focal proliferations,
then neoplastic nodules and hepatocellular carcinomas which
are morphologically and biochemically similar to those of
primary experimental hepatocarcinogenesis (Laishes & Rolfe,
1980; Hanigan & Pitot, 1985; Saeter et al., 1987; Roomi et
al., 1985; Hunt et al., 1982). Transplantation experiments
permit studies of individual separable cell subpopulations
generated during carcinogenesis (Laishes et al., 1980) as well
as of the behaviour of carcinogen-altered cells in an in vivo
environment not exposed to carcinogens (Hanigan & Pitot,
1985).
One interesting feature of carcinogen-altered hepatocytes is
their change in DNA content. We have previously reported a
significant increase in the fraction of diploid hepatocytes
during early stages of liver carcinogenesis induced by
treatment with diethylnitrosamine (DEN) and 2-acetylamino-
fluorene (AAF) (Schwarze et al., 1984; Seglen et al., 1988b).
Moreover, neoplastic nodules and hepatocellular carcinomas
generated in this model have been shown to contain 70-90%
diploid cells, as compared to only 10% in the normal,
polyploid liver (Seglen et al., 1986; Saeter et al., 1988a).
Similar findings have been reported in other models of rat
liver carcinogenesis (Neal et al., 1976; Irving et al., 1977;
Styles et al., 1985; Deleener et al., 1987), indicating that
replacement of normal polyploidising growth by diploid
divisional proliferation may be a fundamental feature of
chemical hepatocarcinogenesis.
To further investigate the stability and importance of this
phenotypic alteration we have studied the DNA content of
isolated nuclei from neoplastic nodules and hepatocellular
carcinomas arising in host liver after intraportal injection of
hepatocytes from syngeneic carcinogen-treated donor rats.
Tumour ploidies have been compared with hepatocytic
ploidy distributions in the surrounding host liver. Further-
more, the relative amounts of diploid and polyploid donor
hepatocytes were varied over a wide range by means of
centrifugal elutriation, in order to study the effects of such
manipulations upon the ploidy patterns of resultant host
liver tumours.
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Finally, we have characterised our transplantation model
in terms of degree of donor cell retention in host liver and
cell dose versus tumour yield, and studied the effect of
secondary promotion in the host with dietary phenobarbi-
tone (PB).
Materials and methods
Donor animal treatment and isolation of donor hepatocytes
Four-week old male rats (70g) of the inbred Wistar Kyoto
strain were subjected to partial hepatectomy (PH) and 24h
later injected intraperitoneally with DEN (50mgkg-1).
Following one week's rest on basal diet, the animals were
fed a semi-synthetic diet (Bio-Serv Inc., Frenchtown, NJ,
USA) containing 0.02% AAF for 4 weeks, then returned to
basal diet. This initiation-promotion regimen produces
multiple neoplastic nodules from 8 weeks after start of
treatment and hepatocellular carcinomas from 4 months
onwards (Seglen et al., 1986). At 6 or 8 weeks after start of
treatment donor hepatocytes were isolated by two-step
collagenase liver perfusion and the cells purified by
differential centrifugation as described previously (Seglen,
1976). Some donor cell suspensions from carcinogen-treated
animals were subjected to centrifugal elutriation (Schwarze et
al., 1986) for the purpose of altering the relative amounts of
diploid and polyploid donor hepatocytes before injection
into the host liver. The viability of donor hepatocytes was in
general in excess of 90% as determined by trypan blue
exclusion.
For control experiments and studies of donor cell
retention in recipient liver, donor hepatocytes were obtained
by collagenase perfusion of livers from normal, untreated 10-
week-old rats.
Measurement of DNA content of donor hepatocytes
Intact donor hepatocytes were stained with mithramycin
(100,ugml-1 in 25% ethanol) and their DNA content
measured in a laboratory-built flow cytometer as previously
described (Schwarze et al., 1984). On average 10,000 cells
were analysed in each sample. Non-parenchymal liver cells
were prepared separately (Seglen, 1976, 1979) and used as an
external diploid standard.
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Intraportal transplantation procedure and host treatment
Our method is similar to the one described by Hanigan &
Pitot (1985). Under halothane or ketaline/xylazine
anaesthesia, male inbred Wistar Kyoto rats (170-200g) were
subjected to PH. Immediately afterwards, donor hepatocytes
suspended in 1.0ml of cold suspension buffer (Seglen, 1976)
were injected slowly (45 s) into the portal circulation through
an ileal tributary vein which was subsequently tied off. For
studies of ploidy distributions in recipient liver tumours, 1.0
or 3.0 x 106 viable donor hepatocytes were injected. For
studies of the influence of donor cell number on tumori-
genesis, the cell dose range was 0.01-3.0 x 106 viable donor
cells.
Following the transplantation procedure, recipient animals
were fed either basal diet throughout or the semi-synthetic
diet containing 0.04% phenobarbitone (PB) until the time of
killing or for a maximum period of 4 months.
Retention of donor cells in recipient liver
Donor hepatocytes were labelled in vitro with 5"Cr by
incubating 500 Ml aliquots of cell suspension (5.0 x 106 cells)
with 5p1 sodium chromate (150-180,Ci) in 0.9% NaCl in a
shaking water bath at 37°C for 3min. This incubation time
was chosen after preceding experiments showing that, at
37°C, no additional labelling was obtained by incubating
cells for longer periods (Figure la). Furthermore, the
labelling obtained was of a very stable nature, with no
significant spontaneous release of 51Cr during in vitro
incubation at 37°C for 2h (Figure lb), during which time
there was only a 10% drop in cell viability (data not shown).
In these experiments, 400 p aliquots of cell suspension were
incubated with 20 pCi of 5"Cr and subsequent cell-bound
radioactivity was determined as described below.
Following incubation, the cells were washed twi¢e and
resuspended in the suspension buffer containing pyruvate
(2.6mgml-1) followed by adjustment of the final cell
concentration to 1.0 x 106 viable cells ml-1. Intraportal
injection of 1 ml of cell suspension was then performed as
described above. Recipient animals were killed by ex-
sanguination through the large retroperitoneal vessels at
various time points from immediately after injection (zero
time point) to one week after transplantation. The livers
were removed, the total liver radioactivity was measured in a
gamma-counter and expressed as per cent of the amount of
injected cell-bound radioactivity. The latter was estimated by
gamma counting of the cell pellet obtained after
centrifugation of 1 ml of labelled donor cell suspension
through a 0.5ml 8% metrizamide/8% sucrose cushion
(Seglen, 1976). For the study of cell retention as a function
of cell dose, recipients were injected with 0.5-10.0 x 106 5tCr-
labelled hepatocytes and all recipients killed 48 h later.
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Figure 1 (a) Effect of incubation time and temperature on
hepatocyte labelling with 5tCr. Labelling efficiency expressed as
per cent of the total incubated radioactivity that becomes cell-
bound; (b) Spontaneous release of cell-bound radioactivity at
37°C following incubation with 5'Cr for 3min at 37°C. Each
value represents the mean+ range of the combined data from two
separate experiments.
In one of the experiments the donor hepatocytes were pre-
labelled in vivo with tritiated thymidine by injecting the
donor animals with 1.0ml 3H-thymidine solution (2.0pCi)
into the penile vein 18.5h after PH. Donor hepatocytes were
isolated 24h after thymidine injection, double-labelled with
51Cr in vitro and transplanted to recipients as described
above. Following sacrifice of the recipients and measurement
of 1Cr-derived radioactivity, the livers were homogenised
in 0.25M sucrose and nuclei were isolated by centrifuga-
tion through 2.3M sucrose in a Beckman SWTi 65 rotor
at 36,000r.p.m. for 30min (Blobel & Potter, 1966). The
isolated nuclei were dissolved in 0.1 N NaOH, 0.4% de-
oxycholic acid and their radioactivity measured in a liquid
scintillation counter. The fraction of cells retained in the
recipient liver was then estimated by relating total recipient
liver nuclear radioactivity to the nuclear radioactivity
measured in the donor cell suspension. Isolated nuclei
displayed no 5ICr activity.
Isolation of host liver tumours and nuclear DNA
measurements
At various times after transplantation of preneoplastic
hepatocytes, collagenase perfusions of the host livers were
performed. Neoplastic nodules and hepatocellular
carcinomas are not dissociated by such portal perfusion due
to their predominantly arterial blood supply (Conway et al.,
1985) and may therefore be removed intact from the initial
cell suspension by filtration through a 250pm nylon mesh
and subsequently quantified as described elsewhere (Saeter et
al., 1988a).
One part of each tumour was used for histological
examination after staining of 100pm sections with Haema-
toxylin and Eosin and classified as neoplastic nodules or
hepatocellular carcinomas according to Squire & Levitt
(1975). From another part of the neoplasm, isolated nuclei
were prepared by the trypsin-detergent method of Vindel0v
et al. (1983) and stained with propidium iodide (17pgml-1
in phosphate-buffered saline). The DNA content of isolated
nuclei was then determined in the flow cytometer (Schwarze
et al., 1984), using nuclei from human splenic lymphocytes
and chicken erythrocytes for standardisation of diploid DNA
content. On average 10,000 nuclei were analysed from each
tumour.
Purified suspensions of hepatocytes from normal livers (2-
4 months after PH), from control hosts (PH+injection of
normal hepatocytes) and from host liver surrounding the
neoplasms were prepared by portal collagenase perfusion
(Seglen, 1976) and DNA content of isolated nuclei was
determined as described above. The procedure for
purification of hepatocytes employing low speed differential
centrifugation effectively eliminates contamination of the
sample by diploid non-parenchymal cells (comprising
approximately 40% of all cells), securing an accurate
determination of purely hepatocellular DNA content (Seglen,
1976; Schwarze & Seglen, 1985; Schwarze et al., 1986).
Nodules and carcinomas induced in our rat liver model
contain only insignificant numbers of non-parenchymal cells
(Figure 3 and Saeter et al., 1988a). Therefore, preparation of
isolated nuclei by mechanical distruption of the neoplasm
yields a good material for specific DNA analysis of neo-
plastic nuclei, as previously demonstrated (Saeter et al.,
1988a).
Ploidy nomenclature
In our analysis of histograms obtained by flow cytometric
DNA measurements of isolated nuclei, diploid nuclei are
those situated in the diploid peak or in the area between the
diploid and tetraploid peaks (diploid S-phase nuclei). For
two reasons, ploidy studies of isolated nuclei will under-
estimate the difference in polyploidisation between tumours
and surrounding livers. Firstly, the 'tetraploid' peak will be
made up of both diploid G2-phase nuclei and true tetraploid
GI-phase nuclei. Single parameter flow cytometry is unable200 G. SAETER et al.
to distinguish between these two classes. In our analysis, all
nuclei situated in the 'tetraploid' peak are counted as GI
tetraploid, thus somewhat underestimating the fraction of
nuclei belonging to the diploid divisional cycle. Secondly, in
normal liver, only approximately half of the diploid nuclei
stem from mononucleated diploid cells, the rest being
contributed by binucleated tetraploid cells (containing two
diploid nuclei) (Seglen et al., 1988b; Saeter et al., 1988b).
Thus, in normal liver, the fraction of diploid hepatocytes will
be overestimated if represented by the fraction of isolated
diploid nuclei. However, as single cell suspensions are
difficult to prepare from tumours, isolated nuclei were
prepared from both tumours and surrounding or normal
livers to allow ploidy comparisons. Indeed, for the purpose
of demonstrating the altered tendency for polyploidisation
taking place during hepatocarcinogenesis, analysis of isolated
nuclei suffices, as will be demonstrated in the present work.
Ploidy analysis of donor hepatocytes was performed on
intact whole cells. This measurement provides true values for
the fraction of diploid mononucleated donor cells (apart
from a slight underestimation due to two-cell aggregate
formation).
Identifiable nuclear subpopulations deviating in DNA
content from the diploid, tetraploid or octoploid areas were
considered to have aneuploid DNA content.
Histochemical studies
Frozen sections were made from carcinomas and from
biopsies taken from the distal part of the right anterior lobes
of tumour-bearing and normal host livers prior to perfusion
and were subsequently stained for gamma-glutamyl trans-
peptidase (GGT) activity according to Rutenburg et al.
(1969). GGT analysis was also done on donor cell
suspensions from both carcinogen-treated and normal livers.
Reagents
Diethylnitrosamine and 2-acetylaminofluorene were obtained
from Sigma Chemical Co. (St Louis, MO, USA). Mithra-
mycin was from Pfizer Ltd (Sandwich, UK) and propidium
iodide from Calbiochem AG (Lucerne, Switzerland). "Cr (as
sodium chromate) and 3H-thymidine were purchased from
Amersham International (Amersham, UK).
Results
Retention of donor cells in recipient liver
Figure 2 shows the fraction of donor cell radioactivity
remaining in recipient liver as a function of time. The figure
indicates that there is a rapid disappearance of injected cells
within the first hour followed by a slow decline during the
next 24h. Subsequently the curves level out and remain
stable, indicating that in the order of 20% of the injected
hepatocytes are finally retained by the recipient liver.
Separate experiments utilising centrifugal elutriation of
donor cell suspensions before labelling and injection showed
that small (diploid) hepatocytes were retained to the same
degree as larger (tetraploid and octoploid) cells (data not
shown).
Table I shows that the percentage of cells remaining 48h
after intraportal injection was the same at all cell
concentrations, i.e. the number of cells retained was pro-
portional to the number of cells injected. After injection of
hepatocytes from carcinogen-treated rats, the number of
nodules and carcinomas appearing in the host liver was
likewise roughly proportional to the number of cells injected
(Table II).
Tumour reponse in host liver
Neoplastic nodules and even hepatocellular carcinomas
started appearing in host liver as early as 8 weeks after the
intraportal injection of hepatocytes isolated from the preneo-
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Figure 2 Fraction of cell-bound radioactivity recovered in
recipient liver from immediately after intraportal injection of
labelled hepatocytes (time point zero) to I week post-transplant.
0, donor hepatocytes labelled in vitro with "Cr. Values are the
means of four experiments, each experiment containing two or
three animals per time point. In one experiment donor
hepatocytes were alsd pre-labelled in vivo with tritiated
thymidine. The fraction of recovered 3H-radioactivity was
measured separately (A).
Table I Relationship between the number of cells injected and the
number of cells retained by the recipient liver
No. of viable % Radioactivity No. of cells
cell injected recovered retained
(x 106) +s.e. (x 106)+s.e.
0.5 16.6+2.2 0.083+0.011 (2)
1.0 18.3+2.5 0.183+0.025 (3)
3.0 18.6+4.4 0.558+0.132 (2)
5.0 18.9+3.1 0.945+0.155 (2)
10.0 19.7+ 1.0 1.970+0.100 (2)
The percentage of injected cell-bound radioactivity recovered in
recipient liver 48h after intraportal injection of 5"Cr-labelled cells
was measured, and the number of cells retained was calculated on
this basis. The number of animals is given in parentheses.
Table II Tumour formation in host liver as a function of cell
number transplanted from preneoplastic donor liver
No. of viable cells No. of tumours
injected ( x 105) per animal
0.1 0.0 (4)
0.3 0.0 (4)
1.0 0.3+0.3 (3)
3.0 0.5+0.3 (4)
10.0 6.3+ 1.5 (6)
30.0 9.5+2.2 (6)
Donor hepatocytes were isolated 8 weeks after initiation of
carcinogen treatment (PH+DEN+AAF). Host liver tumours were
isolated 12 weeks after transplantation; each value is the mean+s.e.
of the number of animals given in parentheses.
plastic livers of carcinogen-treated rats. With the injection of
3 x 106 viable donor cells and host treatment with PB, the
number of tumours per host liver after 12 weeks averaged
9.3 +2.3 (mean +s.e. of six animals). Approximately 15% of
tumours at this stage were histologically classified as hepato-
cellular carcinomas measuring from 3.0 to 6.0 mm in
diameter, the remainder being neoplastic nodules, of which
the majority measured from 0.5 to 3.0mm. The histological
features of these tumours (Figure 3) were indistinguishable
from those of the nodules and hepatocellular carcinomas of
primary chemical hepatocarcinogenesis. From 4 months
onwards the majority of host livers displayed multipleDIPLOID TUMOURS FROM HEPATOCYTES 201
Figure 3 H & E sections of host liver tumours isolated by collagenase perfusion 12 weeks after transplantation. (a) Neoplastic
nodule measuring 2.0mm in diameter; (b) Moderately differentiated hepatocellular carcinoma, 4.0mm in diameter. Both are x 140.
hepatocellular carcinomas measuring up to several cm in
diameter.
Table III shows the promotional effect of PB in this
transplantation model. Three months after cell injection all
hosts fed PB had tumours, either both nodules and
carcinomas (60%) or nodules only (40%). In contrast,
approximately 60% of the hosts fed normal diet were
without tumours. The remaining 40% had nodules only; no
tumours at this time point were classified as carcinomas. In
addition there was a tendency for the livers of PB-fed
recipients to contain more nodules per nodule-positive liver
than the control recipients (5.0 + 1.7 versus 1.3+0.3; P>0.05,
t test). At 8-9 months several hosts had carcinomas even
without previous treatment with PB. Apparently PB is not
necessary for carcinoma formation in this transplantation
model, but it accelerates the process considerably, thus
acting as a secondary promoter.
No animal injected with normal hepatocytes developed
liver tumours at any time point (Table III).
DNA content of donor and host hepatocytes and of tumours
arising in host liver
Ploidy distributions were determined by flow cytometry of
nuclei isolated from 74 neoplastic nodules, 78 hepatocellular
carcinomas and suspensions of surrounding hepatocytes,
all isolated from host liver 2-9 months after intraportal
injection of hepatocytes from preneoplastic carcinogen-
treated liver. In addition, nuclear ploidy determinations
were performed on samples from nine normal livers. Figure 4
shows typical frequency histograms of the DNA content of
nuclei isolated from a nodule, a carcinoma and from
surrounding host hepatocytes. The increase in the relative
amount of diploid nuclei in the tumours as compared to the
surrounding (mostly tetraploid) host liver is evident. Thus, in
nodules and carcinomas, 70-90% of the nuclei were in
general diploid. In normal liver and in liver surrounding host
tumours, only 20% of hepatocytic nuclei were diploid (Table
IV). More than half of the tumours contained in excess of
80% diploid nuclei and all tumours were more diploid than
any of the suspensions of surrounding host hepatocytes
(Figure 5). Carcinomas isolated from hosts fed normal diet
contained an even higher fraction of diploid nuclei than
carcinomas isolated from hosts fed PB (Table IV). Too few
nodules were available from host fed normal diet to assess
the effect of PB on nodule ploidy. No nodules displayed
aneuploid DNA peaks.
Like in our model of primary experimental hepatocarcino-
genesis (Saeter et al., 1988a), aneuploid tumours were rarely
found in the transplantation model despite good peak re-
Table III Phenobarbitone (PB) promotion of tumour development in host livers after transplantation
of hepatocytes from preneoplastic donor livers
Time after transplantation
Donor Host 3 months 5-9 monthsa
hepatocytes treatment Nodules only Carcinomas Nodules only Carcinomas
Normal PH+PB 0/4 0/4 0/7 0/7
Preneoplastic PH only 3/7 0/7 3/7 3/7
Preneoplastic PH + PB 5/12 7/12 4/12 7/12
Hepatocytes from neoplastic donor livers were isolated 6-8 weeks after initiation of carcinogen
treatment (PH+DEN+AAF) and normal donor cells from 12-week-old untreated rats. Host rats
received PH only or PH+ PB. The number of tumour-bearing hosts is given as the fraction of the total
number of animals in that group; aThe majority of rats receiving preneoplastic cells + PB had to be
killed after 5-6 months due to debilitating tumour burden, whereas hosts fed normal diet were killed
after 8-9 months.202 G. SAETER et al.
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Figure 4 Frequency distribution histograms of flow
cytometrically recorded DNA content in isolated nuclei from (a)
host hepatocytes surrounding tumours; (b) Neoplastic nodule
(2 mm in diameter) isolated 3 months after intraportal
transplantation of donor hepatocytes from a carcinogen-treated
rat; (c) Hepatocellular carcinoma (5mm) isolated 9 months after
transplantation of cells from a carcinogen-treated rat.
solution with a mean coefficient of variation below 4.5%.
However, six hepatocellular carcinomas (8%) were found to
contain small anaeuploid cell populations in the hyper-
diploid, hypotetraploid or hypertetraploid region (Figure 6).
These tumours were nevertheless predominantly diploid, the
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Figure 5 Frequency distribution of per cent diploid nuclei in
146 euploid tumours (neoplastic nodules and carcinomas:
Hatched columns) arising 2-9 months after intraportal injection
of preneoplastic donor cells. The tumours were isolated from a
total of 75 host livers. Nine different donor hepatocyte
suspensions were used. Open columns: Per cent diploid nuclei in
11 hepatocyte suspensions from surrounding host livers.
aneuploid subpopulations comprising only 10-15% of all
nuclei. No correlation was found between the appearance of
aneuploidy and tumour size, time of isolation or host
treatment with PB. In some experiments, additional
recipients were given suspensions that were enriched with or
derprived of diploid donor hepatocytes by means of
centrifugal elutriation (Schwarze et al., 1986). Figure 7 shows
that regardless of the relative content of diploid cells in the
donor cell suspension, resulting host liver nodules and
carcinomas were always predominantly diploid.
GGT-expression in tumours and host liver
All 18 host hepatocellular carcinomas tested displayed hyper-
expression of GGT in large areas of the tumour tissue. Four
out of five biopsies from surrounding liver showed focal
proliferations of positive hepatocytes, presumably derived
from GGT-hyperexpressive donor cells. This is supported by
the finding that livers of carcinogen-treated donor rats
contained 18.9 +3.0% GGT-positive hepatocytes (n = 12), as
compared to no GGT-positive hepatocytes in control rats of
the same age (n =4). Biopsies from five control host livers
transplanted with normal cells only displayed positive
staining in a very few scattered hepatocytes and in bile
canalicular cells.
Discussion
Tumours arising in host liver after intrahepatic
transplantation of carcinogen-altered hepatocytes are
presumed to be derived from proliferation and progression
of donor cells (Laishes & Rolfe, 1980; Hanigan & Pitot,
1985). In the presently described model as many as 20% of
the injected hepatocytes are retained by the recipient liver in
Table IV Nuclear ploidy distributions in euploid hepatocellular tumours developing in
host livers following intraportal transplantation of hepatocytes from preneoplastic donor
livers
Sample type Tumour Nuclear ploidy (%±s.e.)
(host treatment) No.a diam.(mm) 2N 4N 8N
Normal liverb 9 21.8+2.1 69.8+1.6 8.5+0.8
Host liver 11 20.0+0.9 69.4+0.8 10.6+0.9
Nodules 74 2.6+0.3 73.2+ 1.9 24.2+1.7 2.6+0.3
Carcinomas (+PB) 61 10.0+ 1.1 78.6+ 1.8 19.9+1.7 1.5+0.2
(-PB) 11 21.6+3.6 90.6+0.7 9.1+0.6 0.3+0.1
(all) 72 12.0+1.1 80.4+1.6 18.3+1.5 1.3+0.2
aNumber of tumours or host livers. Donor hepatocytes were from carcinogen-treated
rats 6-8 weeks after treatment start (PH+DEN+AAF). Hosts were killed 2-9 months
after transplantation. PB indicates host promotion with phenobarbital; bHepatocytes
isolated 2-4 months after PH.
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Figure 6 Host hepatocellular carcinomas with small aneuploid
nuclear subpopulations (indicated by arrows); (a) Hyperdiploid
population in tumour (35 mm in diameter) isolated 9 months
after transplantation; (b) Hypotetraploid population in tumour
(2.5mm) isolated after 2 months; (c) Hypertetraploid population
in tumour (3.5mm) isolated after 2 months.
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a stable fashion, providing a sufficient number of cells
(200,000 under standard conditions) for extensive tumour
development. The 51Cr label used in our experiments
functions as a cellular marker that is rapidly lost and not
reutilised upon cellular lysis (Zawydiwski & Duncan, 1978);
retention of 51Cr therefore reflects the retention of intact
cells. The stability of the marker is illustrated by our results
(Figure 1). 3H-Thymidine-labelled DNA is likewise only
preserved by intact cells, indicating that the permanently
retained radioactivity represents surviving donor hepatocytes.
Weiss et al. (1983) found that a comparable fraction of
labelled melanoma cells was retained in mouse liver
following intraportal injection.
The reasonably linear dose-response relationship observed
between the number of cells injected, the number of cells
retained and the number of tumours formed in the recipient
liver indicates that transplanted cells are indeed the pre-
cursors of the tumours. This is supported by the fact that
tumours were never observed in the hosts unless they
received donor cells from DEN-initiated rats. Tumour
formation was then accelerated by using PB as a secondary
(host) promoter. PH+PB, in the absence of transplants or
after transplantation of normal hepatocytes, produced no
tumours. In primary carcinogenesis PB, which lacks
initiating activity, similarly depends on the presence of
initiated cells to promote tumour formation (Watanabe &
Williams, 1978; Schulte-Hermann et al., 1982). It should be
pointed out, however, that donor hepatocytes from
carcinogen-treated livers eventually produced tumours even
without PB promotion. In contrast to this, Hanigan & Pitot
(1985) reported PB to be essential for formation of focal
changes and tumours in host liver, at least within the time
span studied. This difference may be due to the different
carcinogen regimens used for donor animal treatment and
the different rat strains used.
Accepting that in the current model the host liver tumours
arise from injected cells, it becomes possible to study the fate
of phenotypic alterations in preneoplastic donor hepatocytes
following their transfer to and proliferation in an
environment not affected by carcinogens.
Experimental hepatocarcinogenesis utilising DEN as
initiating agent and AAF as promoter involves a switch in
hepatocellular proliferation from normal polyploidisation to
a diploid-diploid divisonal growth pattern (Schwarze et al.,
1984; Seglen et al., 1986; Saeter et al., 1988a). Six to eight
weeks after start of treatment (end of AAF promotion
period and time point for preneoplastic donor cell isolation
in this study), purified hepatocyte suspensions contain 40-
60% diploid cells as opposed to 10-15% in untreated liver
(Schwarze et al., 1984; Seglen et al., 1986; Saeter et al.,
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Figure 7 Fraction of diploid nuclei (% of total) in host tumours as a function of the diploid cell content of the donor cell
suspension. 0, 0, tumours arising from an unfractionated suspension of preneoplastic cells. A, A, tumours arising from donor
cells subjected to centrifugal elutriation. Open symbols, neoplastic nodules; filled symbols, hepatocellular carcinomas. Hatched area,
mean number of diploid nuclei in surrounding hepatocytes+s.e.
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1988b). This is due to a block in polyploidisation imposed by
AAF, which may be part of the mechanism of promotion of
this agent (Seglen et al., 1988a; Saeter et al., 1988b). This
new proliferation pattern is constitutively maintained in
neoplastic nodules and in carcinomas which uniformly
contain 70-90% diploid cells regardless of the time point of
isolation (Saeter et al., 1988a). The present study shows that
following intraportal transplantation of preneoplastic
hepatocytes generated in this model, resulting host liver
nodules and carcinomas are similarly totally dominated by
diploid nuclei. Non-parenchymal (diploid) cells were scarce
in the tumours (Figure 3), and do not significantly
contribute to the diploid peak. Furthermore, binucleated
(2 x 2N) cells have been shown to make up only 6% of cells
in carcinomas as compared to 20-30% in normal rat liver
(Saeter et al., 1988a). Thus the vast majority of diploid
nuclei in host nodules and carcinomas stem from mono-
nucleated diploid hepatocytes. As previously mentioned,
single parameter flow cytometric DNA measurements are
unable to distinguish between diploid G2 and tetraploid GI
nuclei. Thus, since more than half ofthe tumours contained
80-95% diploid nuclei (GI plus S-phase) whereas no
tumours had in excess of 95%, a minimum of 5% are
probably diploid G2 nuclei registered in the tetraploid peak.
Truly tetraploid (G1) nuclei are therefore very scarce in
tumours; indeed the virtual absence of tetraploid G2 nuclei
(octoploid peak) testifies to the insignificance of tetraploid
proliferation in the majority of tumours. In contrast, the
large tetraploid peak in normal liver represents mainly truly
tetraploid G1 phase nuclei, as supported by the presence of a
significant population in the octoploid area (tetraploid G2
and octoploid GI nuclei).
Unlike AAF, which blocks hepatocellular polyploidisation
and thus expands the fraction of proliferating diploid
hepatocytes (Seglen et al., 1988a; Saeter et al., 1988b), PB
does not significantly change the hepatocellular ploidy
distributions in normal (regenerated) liver (Seglen et al.,
1988b). Some previous reports have even indicated that PB
induces increased polyploidisation when stimulating the adult
rat liver to grow (Staubli et al., 1969; Argyris, 1974). The
pronounced degree of diploidy seen in nearly all host liver
tumours must therefore reflect a constitutive growth pattern
which is not altered when tumour growth is stimulated by
PB. PB would thus appear capable of stimulating poly-
ploidising as well as non-polyploidising hepatocyte
proliferation, the growth pattern being determined by the
nature of the cells rather than by the promoter.
Hepatocellular polyploidisation is considered to be an
irreversible process and a feature of cellular differentiation
(Carriere, 1969; Brodsky & Uryvaeva, 1977). Assuming that
this irreversibility holds true also for cells involved in the
hepatocarcinogenic process, only diploid precursor cells can
give rise to diploid tumours. In our model of primary
hepatocarcinogenesis, the fraction of diploid hepatocytes is
increased (by AAF) 4-5 times above normal at the preneo-
plastic stages (Schwarze et al., 1984; Seglen et al., 1988a;
Saeter et al., 1988b). In DEN-initiated livers, the fraction of
diploid hepatocytes remains significantly elevated even after
AAF withdrawal, paralleling the retention of hepatocytes
with elevated GGT levels (Seglen et al., 1988a). Some
carcinogen-altered cells have thus come to express both
phenotypic alterations in a constitutive manner.
Subsequently developing neoplastic nodules and hepato-
cellular carcinomas are likewise predominantly diploid
(Saeter et al., 1988a; Seglen et al., 1988a) as well as GGT-
positive (our unpublished results), suggesting the possibility
of a precursor-product relationship.
The present study shows that following transplantation of
preneoplastic cells generated in this model to a new liver
environment in syngeneic hosts, the resulting tumours are
still predominantly diploid (and GGT-positive), regardless of
the ploidy composition of the donor cell suspension.
Accordingly, it is reasonable to assume that it is the diploid,
GGT-positive cells present in all donor suspensions that give
rise ot the host liver tumours. In the few tumours with small
aneuploid subpopulations, the majority (75-85%) of nuclei
were nevertheless diploid (Figure 6), indicating that the
aneuploid clones have been formed by derangement of an
already established diploid-diploid proliferation pattern.
These results illustrate the fundamental and constitutive
nature of the switch in hepatocellular proliferation from a
normal polyploidising programme to a non-polyploidising
diploid divisional programme, seen at all stages in our model
of experimental hepatocarcinogenesis. The reports of similar
findings in other models (Neal et al., 1976; Irving et al.,
1977; Styles et al., 1985; Deleener et al., 1987) may well
indicate that this is a general feature of liver carcinogenesis.
This work was generously supported by The Norwegian Cancer
Society.
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